MicroRNA-451 dictates the anoikis resistance of osteosarcoma by targeting Rab14

Area of Science:

• Molecular Oncology
• Cancer Biology
• Cell Biology

Background:

• Cancer cells exhibit anoikis resistance, enabling survival and metastasis after detachment from the primary tumor.
• Mechanisms of anoikis resistance in osteosarcoma (OS) are not fully understood.
• MicroRNAs (miRNAs) are implicated in cancer progression and malignant phenotypes.

Purpose of the Study:

• To investigate the role of miRNAs in anoikis resistance in osteosarcoma cells.
• To identify specific miRNAs and their targets involved in anoikis resistance in OS.
• To elucidate the molecular mechanisms underlying anoikis resistance in osteosarcoma.

Main Methods:

• Screening of 9 dysregulated miRNAs in OS for their role in anoikis.
• Bioinformatics prediction and luciferase reporter assays to identify miRNA targets.
• In vitro assays to assess anoikis, anchorage-independent growth, and gene/protein expression.
• In vivo studies to evaluate the effect of miR-451 on lung metastasis.

Main Results:

• miR-451 was identified as a key factor in anoikis resistance and anchorage-independent growth of OS cells.
• miR-451 was downregulated in OS cells; its re-expression promoted anoikis, while inhibition protected cells.
• Rab14 was confirmed as a direct target of miR-451, with miR-451 downregulating Rab14 expression.
• Silencing Rab14 mimicked miR-451's effect on anoikis, and Rab14 restoration abrogated miR-451's tumor suppressor function.
• Overexpression of miR-451 significantly suppressed lung metastasis of OS cells.

Conclusions:

• The miR-451/Rab14 axis represents a novel mechanism contributing to anoikis resistance in osteosarcoma.
• miR-451 acts as a tumor suppressor by targeting Rab14, inhibiting anoikis resistance, and reducing metastasis.
• Targeting the miR-451/Rab14 pathway may offer therapeutic strategies for osteosarcoma.